{"id":"https://openalex.org/W4402455352","doi":"https://doi.org/10.1016/j.medj.2024.08.001","title":"The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis","display_name":"The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis","publication_year":2024,"publication_date":"2024-09-11","ids":{"openalex":"https://openalex.org/W4402455352","doi":"https://doi.org/10.1016/j.medj.2024.08.001","pmid":"https://pubmed.ncbi.nlm.nih.gov/39265579"},"language":"en","primary_location":{"id":"doi:10.1016/j.medj.2024.08.001","doi":"https://doi.org/10.1016/j.medj.2024.08.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.medj.2024.08.001","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.medj.2024.08.001","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053861062","display_name":"Marta Vaz Batista","orcid":"https://orcid.org/0000-0001-5791-2092","observed_orcids":["https://orcid.org/0000-0001-5791-2092"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Vaz Batista","raw_affiliation_strings":["Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal; Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal; Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090108117","display_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","orcid":"https://orcid.org/0000-0003-4238-2046","observed_orcids":["https://orcid.org/0000-0003-4238-2046","https://orcid.org/0009-0004-2204-2014"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain","institution_ids":["https://openalex.org/I4210102398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024818826","display_name":"Laia Garrig\u00f3s","orcid":"https://orcid.org/0009-0006-4865-227X","observed_orcids":["https://orcid.org/0009-0006-4865-227X"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laia Garrig\u00f3s","raw_affiliation_strings":["International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Hospital Universitari Dexeus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Hospital Universitari Dexeus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029469753","display_name":"Jos\u00e9 \u00c1. Garc\u00eda-S\u00e1enz","orcid":"https://orcid.org/0000-0001-6880-0301","observed_orcids":["https://orcid.org/0000-0001-6880-0301"]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 \u00c1ngel Garc\u00eda-S\u00e1enz","raw_affiliation_strings":["Hospital Cl\u00ednico San Carlos, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Cl\u00ednico San Carlos, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019922542","display_name":"Patricia Cortez","orcid":"https://orcid.org/0009-0009-4665-4791","observed_orcids":["https://orcid.org/0009-0009-4665-4791"]},"institutions":[{"id":"https://openalex.org/I4210150844","display_name":"Hospital Ruber Internacional","ror":"https://ror.org/04abjq359","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210150844"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Patricia Cortez","raw_affiliation_strings":["IOB Institute of Oncology, Hospital Ruber Internacional, Quiron Group, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IOB Institute of Oncology, Hospital Ruber Internacional, Quiron Group, Madrid, Spain","institution_ids":["https://openalex.org/I4210150844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016561440","display_name":"Fabricio Racca","orcid":"https://orcid.org/0000-0002-1502-6989","observed_orcids":["https://orcid.org/0000-0002-1502-6989"]},"institutions":[{"id":"https://openalex.org/I4405267828","display_name":"IDCQ Hospitales y Sanidad, S.L.U.","ror":"https://ror.org/04k611z44","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4405267828"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Fabricio Racca","raw_affiliation_strings":["IOB Institute of Oncology, Quiron Group, Madrid, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IOB Institute of Oncology, Quiron Group, Madrid, Barcelona, Spain","institution_ids":["https://openalex.org/I4405267828"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112899140","display_name":"Salvador Blanch","orcid":"https://orcid.org/0009-0008-9553-2179","observed_orcids":["https://orcid.org/0009-0008-9553-2179"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]},{"id":"https://openalex.org/I4210103093","display_name":"Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda","ror":"https://ror.org/01fh9k283","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210103093"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Salvador Blanch","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; Fundaci\u00f3n Instituto Valenciano de Oncolog\u00eda, Valencia, Spain","institution_ids":["https://openalex.org/I4210102398","https://openalex.org/I4210103093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045301167","display_name":"Manuel Ru\u00edz\u2010Borrego","orcid":"https://orcid.org/0000-0002-1181-5622","observed_orcids":["https://orcid.org/0000-0002-1181-5622"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Ruiz-Borrego","raw_affiliation_strings":["Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015542945","display_name":"Adela Fern\u00e1ndez-Ortega","orcid":"https://orcid.org/0000-0001-5921-0246","observed_orcids":["https://orcid.org/0000-0001-5921-0246"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adela Fern\u00e1ndez-Ortega","raw_affiliation_strings":["Instituto Catal\u00e1n de Oncolog\u00eda de Hospitalet de Llobregat (ICO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Catal\u00e1n de Oncolog\u00eda de Hospitalet de Llobregat (ICO), Barcelona, Spain","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100753627","display_name":"Mar\u00eda Fern\u00e1ndez-Abad","orcid":"https://orcid.org/0000-0002-4382-4726","observed_orcids":["https://orcid.org/0000-0002-4382-4726"]},"institutions":[{"id":"https://openalex.org/I189268942","display_name":"Universidad de Alcal\u00e1","ror":"https://ror.org/04pmn0e78","country_code":"ES","type":"education","lineage":["https://openalex.org/I189268942"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Fern\u00e1ndez-Abad","raw_affiliation_strings":["Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain; Alcal\u00e1 de Henares University, Faculty of Medicine, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain; Alcal\u00e1 de Henares University, Faculty of Medicine, Madrid, Spain","institution_ids":["https://openalex.org/I189268942","https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070887037","display_name":"Vega Iranzo","orcid":"https://orcid.org/0000-0001-6183-5173","observed_orcids":["https://orcid.org/0000-0001-6183-5173"]},"institutions":[{"id":"https://openalex.org/I4210127649","display_name":"Hospital General Universitario De Valencia","ror":"https://ror.org/03sz8rb35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127649"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vega Iranzo","raw_affiliation_strings":["Consorci Hospital General Universitari de Val\u00e8ncia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consorci Hospital General Universitari de Val\u00e8ncia, Valencia, Spain","institution_ids":["https://openalex.org/I4210127649"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031395305","display_name":"Mar\u00eda Gi\u00f3n","orcid":"https://orcid.org/0000-0002-6601-3360","observed_orcids":["https://orcid.org/0000-0002-6601-3360"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mar\u00eda Gion","raw_affiliation_strings":["Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031344297","display_name":"Griselda Martrat","orcid":"https://orcid.org/0009-0005-8118-3615","observed_orcids":["https://orcid.org/0009-0005-8118-3615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Griselda Martrat","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003876132","display_name":"Daniel Alcal\u00e1-L\u00f3pez","orcid":"https://orcid.org/0000-0003-2184-1346","observed_orcids":["https://orcid.org/0000-0003-2184-1346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Alcal\u00e1-L\u00f3pez","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048785159","display_name":"Jhudit P\u00e9rez\u2010Escuredo","orcid":"https://orcid.org/0009-0009-1691-1849","observed_orcids":["https://orcid.org/0009-0009-1691-1849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jhudit P\u00e9rez-Escuredo","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082318397","display_name":"Miguel Sampayo-Cordero","orcid":"https://orcid.org/0000-0003-1469-3410","observed_orcids":["https://orcid.org/0000-0003-1469-3410"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miguel Sampayo-Cordero","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030451537","display_name":"Antonio Llombart\u2010Cussac","orcid":"https://orcid.org/0000-0003-4515-8293","observed_orcids":["https://orcid.org/0000-0003-4515-8293"]},"institutions":[{"id":"https://openalex.org/I4210097149","display_name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana","ror":"https://ror.org/0116vew40","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210097149"]},{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]},{"id":"https://openalex.org/I4210119293","display_name":"Hospital Arnau de Vilanova","ror":"https://ror.org/02s7fkk92","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210119293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Antonio Llombart-Cussac","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain; Universidad Cat\u00f3lica de Valencia, Valencia, Spain. Electronic address: antoniollombart@medsir.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain; Universidad Cat\u00f3lica de Valencia, Valencia, Spain. Electronic address: antoniollombart@medsir.org","institution_ids":["https://openalex.org/I4210097149","https://openalex.org/I4210102398","https://openalex.org/I4210119293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024784028","display_name":"Sofia Azambuja Braga","orcid":"https://orcid.org/0000-0002-3163-0174","observed_orcids":["https://orcid.org/0000-0002-3163-0174"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sofia Braga","raw_affiliation_strings":["Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4210102398","display_name":"MedSIR (Spain)","ror":"https://ror.org/00t6sz979","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210102398"]},{"id":"https://openalex.org/I904013037","display_name":"Universidad Europea de Madrid","ror":"https://ror.org/04dp46240","country_code":"ES","type":"education","lineage":["https://openalex.org/I904013037"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. Electronic address: javier.cortes@maj3.health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medica Scientia Innovation Research (MEDSIR) - Oncocl\u00ednicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. Electronic address: javier.cortes@maj3.health","institution_ids":["https://openalex.org/I4210102398","https://openalex.org/I904013037"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5030451537","https://openalex.org/A5051629490"],"corresponding_institution_ids":["https://openalex.org/I4210097149","https://openalex.org/I4210102398","https://openalex.org/I4210119293","https://openalex.org/I904013037"],"apc_list":{"value":9170,"currency":"USD","value_usd":9170},"apc_paid":null,"fwci":9.1967,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.98824818,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"6","issue":"1","first_page":"100502","last_page":"100502"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7997999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7997999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.12759999930858612,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8989999890327454},{"id":"https://openalex.org/keywords/her2-low-breast-cancer","display_name":"HER2-low breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9559999704360962},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.7480000257492065},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7689999938011169},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9160000085830688},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5640000104904175},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7590000033378601},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.4959999918937683},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9226645827293396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7474683523178101},{"id":"https://openalex.org/C2778277180","wikidata":"https://www.wikidata.org/wiki/Q1920586","display_name":"Meningeal carcinomatosis","level":3,"score":0.7449537515640259},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6255060434341431},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5534409284591675},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5394708514213562},{"id":"https://openalex.org/C2991818862","wikidata":"https://www.wikidata.org/wiki/Q2071182","display_name":"Peritoneal carcinomatosis","level":4,"score":0.5219427943229675},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31867313385009766},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.08659085631370544},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055756","descriptor_name":"Meningeal Carcinomatosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055756","descriptor_name":"Meningeal Carcinomatosis","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D055756","descriptor_name":"Meningeal Carcinomatosis","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.medj.2024.08.001","doi":"https://doi.org/10.1016/j.medj.2024.08.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.medj.2024.08.001","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},{"id":"pmid:39265579","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39265579","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.medj.2024.08.001","doi":"https://doi.org/10.1016/j.medj.2024.08.001","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.medj.2024.08.001","pdf_url":null,"source":{"id":"https://openalex.org/S4210167770","display_name":"Med","issn_l":"2666-6340","issn":["2666-6340","2666-6359"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Med","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1937707643","https://openalex.org/W2174658047","https://openalex.org/W2271392525","https://openalex.org/W2373239564","https://openalex.org/W2746646750","https://openalex.org/W2806074020","https://openalex.org/W2899871614","https://openalex.org/W2996630100","https://openalex.org/W3170192455","https://openalex.org/W3191679773","https://openalex.org/W3204932277","https://openalex.org/W4281619692","https://openalex.org/W4281640394","https://openalex.org/W4311116389","https://openalex.org/W4361255817","https://openalex.org/W4366529414","https://openalex.org/W4383896224","https://openalex.org/W4387533767"],"related_works":["https://openalex.org/W4396599092","https://openalex.org/W4282940051","https://openalex.org/W7220721428","https://openalex.org/W4322775125","https://openalex.org/W4401093589","https://openalex.org/W4411285529","https://openalex.org/W4401306179","https://openalex.org/W4401304375","https://openalex.org/W4281619692","https://openalex.org/W4402350734"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":22},{"year":2025,"cited_by_count":30},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2024-09-12T00:00:00"}